StonvexLoading…
StonvexStonvexStonvexCore line items from TACT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.41M | $51.48M | $13.18M | $13.80M |
Operating Income | $771.00K | $-1.42M | $-259.00K | $-273.00K |
Net Income | $766.00K | $-1.24M | $15.00K | $-143.00K |
EPS (Diluted) | $0.07 | $-0.12 | $0.00 | $-0.01 |
Total Assets | $47.89M | $44.77M | $44.98M | $44.55M |
Total Liabilities | $15.60M | $13.65M | $13.21M | $13.26M |
Cash & Equivalents | $18.84M | $20.43M | $20.04M | $17.75M |
Free Cash Flow OCF − CapEx | $-1.03M | $7.56M | $6.97M | $3.40M |
Shares Outstanding | 10.28M | 10.13M | 10.11M | 10.09M |